(Circulation. 1997;95:814-817.)
© 1997 American Heart Association, Inc.
Articles |
Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to Transplantation
the Institute of Medical Microbiology (M.H., B.G., C. von E., R.A.P., G.P.) and the Department of Cardiac, Thoracic and Vascular Surgery (M.W., H.H.S.), The University of Muenster Hospital, Germany.
Background Left ventricular assist devices (LVADs) are increasingly used as a bridge to transplantation. Infection is a frequent and major complication associated with the use of these devices; however, the correlation of infection and outcome has not yet been evaluated in a prospective fashion.
Methods and Results Twenty-five patients (24 male, 1 female) with end-stage cardiac failure and resulting organ dysfunction were included. Patients were bridged with the Novacor N100 portable LVAD (median duration of support, 55 days) and were evaluated prospectively by device surface cultures on explantation, molecular typing of isolates, and correlation of infection with survival to transplant. Twelve (48%) of 25 patients had LVAD infection as defined by recovery of multiple isolates of identical genotype from the device surface. Whereas only 5 (42%) of 12 patients with LVAD infection survived until transplantation, 11 (85%) of 13 patients without infection were successfully transplanted (P<.05). Death of the 7 patients with proven LVAD infection was associated with multiple organ failure or other signs of acute infection.
Conclusions LVAD infection is associated with a significantly decreased survival probability. It does not preclude successful bridging but rather may pose an indication for urgent transplantation.
Key Words: heart-assist device • transplantation • survival • infection
This article has been cited by other articles:
 |
|
 |
|
  J. O. Robertson, C. Lober, N. G. Smedira, J. L. Navia, N. Sopko, and G. V. Gonzalez-Stawinski One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 295 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text]
|
|
|
|
 |
|
 T. Asai, M.-H. Lee, C. Arrecubieta, M. P. von Bayern, C. A. Cespedes, H. M. Baron, M. Cadeiras, T. Sakaguchi, C. C. Marboe, Y. Naka, et al. Cellular coating of the left ventricular assist device textured polyurethane membrane reduces adhesion of Staphylococcus aureus J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chatterjee, G. A. Somerville, C. Heilmann, H.-G. Sahl, H. H. Maurer, and M. Herrmann Very Low Ethanol Concentrations Affect the Viability and Growth Recovery in Post-Stationary-Phase Staphylococcus aureus Populations Appl. Envir. Microbiol., April 1, 2006; 72(4): 2627 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsukui, J. J. Teuteberg, S. Murali, D. M. McNamara, J. R. Buchanan, S. Winowich, E. Stanford, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Biventricular Assist Device Utilization for Patients with Morbid Congestive Heart Failure: A Justifiable Strategy Circulation, August 30, 2005; 112(9_suppl): I-65 - I-72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schmid, M. Schneider, C. Etz, and H. H. Scheld Heart Transplantation in a Patient With a Left Ventricular Assist Device and Methicillin-Resistant Staphylococcus Aureus Infection Ann. Thorac. Surg., November 1, 2004; 78(5): 1820 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matsumiya, Y. Miyamoto, N. Fukushima, O. Monta, Y. Sawa, and H. Matsuda Intraabdominal placement of a Novacor ventricular assist system by using an expanded polytetrafluoroethylene pouch Ann. Thorac. Surg., May 1, 2004; 77(5): 1851 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Granfeldt, B. Koul, L. Wiklund, B. Peterzen, U. Lonn, A. Babic, and H. C. Ahn Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients Ann. Thorac. Surg., December 1, 2003; 76(6): 1993 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Baddour, M. A. Bettmann, A. F. Bolger, A. E. Epstein, P. Ferrieri, M. A. Gerber, M. H. Gewitz, A. K. Jacobs, M. E. Levison, J. W. Newburger, et al. Nonvalvular Cardiovascular Device-Related Infections Circulation, October 21, 2003; 108(16): 2015 - 2031. [Full Text] [PDF]
|
|
|
|
|
|
M. Williams, J. Casher, N. Joshi, T. Hankinson, M. Warren, M. Oz, Y. Naka, and D. Mancini Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Holman, B. K. Rayburn, D. C. McGiffin, B. A. Foley, R. L. Benza, R. C. Bourge, L. J. Pinderski, and J. K. Kirklin Infection in ventricular assist devices: prevention and treatment Ann. Thorac. Surg., June 1, 2003; 75(90060): S48 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P. Siegenthaler, J. Martin, K. Pernice, T. Doenst, S. Sorg, G. Trummer, O. Friesewinkel, and F. Beyersdorf The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 748 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Banayosy, L. Arusoglu, L. Kizner, M. Morshuis, G. Tenderich, W. E. Pae Jr, and R. Korfer Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure Ann. Thorac. Surg., May 1, 2003; 75(5): 1469 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matsumiya, M. Nishimura, Y. Miyamoto, Y. Sawa, and H. Matsuda Successful treatment of Novacor pump pocket infection by omental transposition Ann. Thorac. Surg., January 1, 2003; 75(1): 287 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen and R. F. Padera Jr. Cardiac Surgical Pathology Card. Surg. Adult, January 1, 2003; 2(2003): 119 - 185. [Full Text]
|
|
|
|
|
|
S. Westaby, R. Jarvik, A. Freeland, D. Pigott, D. Robson, S. Saito, P. Catarino, and O. H. Frazier Postauricular percutaneous power delivery for permanent mechanical circulatory support J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 977 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gordon, S. K. Schmitt, M. Jacobs, N. M. Smedira, M. Goormastic, M. K. Banbury, M. Yeager, J. Serkey, K. Hoercher, and P. M. McCarthy Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann. Thorac. Surg., September 1, 2001; 72(3): 725 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Vilchez, M. C. McEllistrem, L. H. Harrison, K. R. McCurry, R. L. Kormos, and S. Kusne Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support Ann. Thorac. Surg., July 1, 2001; 72(1): 96 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Banayosy, R. Korfer, L. Arusoglu, L. Kizner, M. Morshuis, H. Milting, G. Tenderich, O. Fey, and K. Minami Device and patient management in a bridge-to-transplant setting Ann. Thorac. Surg., March 1, 2001; 71 (2007): S98 - S102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Deng, M. Loebe, A. El-Banayosy, E. Gronda, P. G. M. Jansen, M. Vigano, G. M. Wieselthaler, B. Reichart, E. Vitali, A. Pavie, et al. Mechanical Circulatory Support for Advanced Heart Failure : Effect of Patient Selection on Outcome Circulation, January 16, 2001; 103(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. de Jonge, H. R. Laube, P. M. Dohmen, V. Ivancevic, and W. F. Konertz Diagnosis and management of left ventricular assist device valve-endocarditis: LVAD valve replacement Ann. Thorac. Surg., October 1, 2000; 70(4): 1404 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D.T. Tjan, B. Asfour, D. Hammel, C. Schmidt, H. H. Scheld, and C. Schmid Wound complications after left ventricular assist device implantation Ann. Thorac. Surg., August 1, 2000; 70(2): 538 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Loisance, P. G.M. Jansen, D. R. Wheeldon, and P. M. Portner Long-term mechanical circulatory support with the wearable Novacor left ventricular assist system Eur. J. Cardiothorac. Surg., August 1, 2000; 18(2): 220 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A El-Banayosy, L Arusoglu, L Kizner, O Fey, K Minami, and R Korfer Complications of circulatory assist Perfusion, July 1, 2000; 15(4): 327 - 331. [PDF]
|
|
|
|
|
|
C. Schmid, M. Wilhelm, M. Rothenburger, D. Nabavi, M. C. Deng, D. Hammel, and H. H. Scheld Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 331 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmid, D. Hammel, M. C. Deng, M. Weyand, H. Baba, T. D. T. Tjan, G. Drees, N. Roeder, C. Schmidt, and H. H. Scheld Ambulatory Care of Patients With Left Ventricular Assist Devices Circulation, November 9, 1999; 100 (2009): II-224 - II-228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Banayosy, M. Deng, D.Y. Loisance, H. Vetter, E. Gronda, M. Loebe, and M. Vigano The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 835 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Goldstein, M. C. Oz, and E. A. Rose Implantable Left Ventricular Assist Devices N. Engl. J. Med., November 19, 1998; 339(21): 1522 - 1533. [Full Text] [PDF]
|
|
|
|
|
|
C. Schmid, M. Weyand, D. G. Nabavi, D. Hammel, M. C. Deng, E. B. Ringelstein, and H. H. Scheld Cerebral and Systemic Embolization During Left Ventricular Support With the Novacor N100 Device Ann. Thorac. Surg., June 1, 1998; 65(6): 1703 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hunt and O.H. Frazier Mechanical Circulatory Support and Cardiac Transplantation Circulation, May 26, 1998; 97(20): 2079 - 2090. [Full Text] [PDF]
|
|